Recent scientific research has found that inflammatory substances and cytokines in the brain of patients with depression are significantly higher. To put it simply, the brain is in a state of "fever". Imaging studies have also found that most patients with depression have poor blood flow and metabolism in the left prefrontal lobe, while the right side is overactivated. After scientific evidence that depression is related to the imbalance of cerebral cortex and nerve state, the medical community generally believes that "repetitive transcranial magnetic stimulation (rTMS) therapy" can provide a new treatment option for patients with depression.
What is "repetitive transcranial job email list magnetic stimulation (rTMS) therapy"? Director Cai Mengzhao explained that this is a method of using magnetic coils to create continuous and regular repetitive electromagnetic pulses, so that the magnetic field reaches the cerebral cortex through the skull. It is a new type of treatment method that stimulates the disordered brain area rapidly and repeatedly through current changes, promotes blood circulation in the brain, and normally activates and inhibits metabolism and neural activity.
In fact, this technology has been used in Europe and the United States for many years. Taiwan was approved by the Food and Drug Administration in 2018 and can be used for the treatment of severe depression, especially those with poor drug response and poor drug tolerance. Treatment-Refractory Depression,” as well as in patients with intolerable medication side effects and poor medication adherence.